Cardiac Biomarkers in Pediatric Cardiomyopathy

Cardiac Biomarkers in Pediatric Cardiomyopathy

To determine the ability of established and novel cardiac biomarkers to predict short- and long-term outcomes.

Are you Eligible? (Inclusion Criteria)

Diagnosis at 18 years of age or less with dilated, hypertrophic, or restrictive cardiomyopathy.

Specialty Area(s)

Trial Location

NYP/Columbia
New York, NY 10032
United States